Market outlook of the global viral hepatitis and retrovirus diagnostic tests market
Diagnostic tests for viral hepatitis and retrovirus aid in screening, diagnosing, and managing diseases in humans. The market for viral hepatitis and retrovirus diagnostic tests is influenced by factors like the growing awareness of diagnostic tests among the populace, rapid advances in technology, and augmented number of product launches and approvals from regulatory authorities. These factors are expected to account for this market’s impressive growth rate of more than 10% by 2019.
In this market study, Technavio’s market research analyst has estimated eminent factors, such as the augmented demand for automation and system integration, to impel market growth during the forecast period. Fully automated and semi-automated systems are more efficient and productive than conventional systems and, therefore, are expected to fuel market growth in the next four years.
Geographical segmentation of the viral hepatitis and retrovirus diagnostic tests market
Geographically, the Americas are expected to account for more than 44% of the total market share by 2019. Factors like the advent of insurance programs like Medicaid and the high prevalence of chronic and infectious diseases such as hepatitis A, B, and C are expected to account for this region’s high market dominion during the forecast period.
Competitive landscape and key vendors
Competition in this market is intense due to the augmented availability of advanced IVD assays and instruments from numerous vendors. Large vendors in this market focus more on increasing their POC product portfolio for HIV and hepatitis detection as it helps them to gain traction in this market.
Large vendors in this market are -
- Abbott Diagnostics
- Alere
- Chembio
- DiaSorin
- Roche Diagnostics
Other prominent vendors in this market are Apothecaries Sundries Manufacturing, AOV International, Amkay Products, Beckman Coulter, Becton Dickinson, Bhat Bio-tech, Bioneovan, bioMerieux, Bio-Rad, Cepheid, Enzo Biochem, Fujirebio, Gemc Technology (Zhengzhou) Co, Grifols , Hangzhou Deangel Biological Engineering Co, Hologic, Hangzhou Heo Bio-Tech, Horiba, Innovation Biotech (Beijing) Co, Jaksh Enterprises, Krishco Medical Products, Micro Sidd, Nantong Egens Biotechnology Co, Nexus Lifecare, Ortho-Clinical Diagnostics, Qingdao Hightop Biotech Co, Qiagen, Scienion, SeraCare, Shanghai Kehua Bio-engineering, Span Diagnostics, Synergy Healthcare, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Transasia Bio-Medicals, Wako, YVR Medivision, and Zhuhai Encode Medical Engineering.
Growth drivers, challenges, and upcoming trends: Diagnostic tests
Technavio analysts estimate upcoming trends, like the augmented demand for biomarker-based tests, to spur market growth during the forecast period. Biomarkers aid in the detection of a disease and are useful for high-growth clinical areas like infectious diseases. Since biomarkers are envisaged to replace conventional drug therapeutics in the future, vendors are increasingly developing cost-effective biomarker-based tests to augment their market penetration.
This report provides a number of factors contributing to the adoption, limitations, and opportunities of the global viral hepatitis and retrovirus diagnostic tests market. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.
Key questions answered in the report include
- What will the market size and the growth rate be in 2019?
- What are the key factors driving the global viral hepatitis and retrovirus diagnostic tests market?
- What are the key market trends impacting the growth of the global viral hepatitis and retrovirus diagnostic tests market?
- What are the challenges to market growth?
- Who are the key vendors in the global viral hepatitis and retrovirus diagnostic tests market?
- What are the market opportunities and threats faced by the vendors in the global viral hepatitis and retrovirus diagnostic tests market?
- Trending factors influencing the market shares of the EMEA, Americas, and APAC?
- What are the key outcomes of the five forces analysis of the global viral hepatitis and retrovirus diagnostic tests market?
Technavio also offers customization on reports based on specific client requirement.
Related reports
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview
Hepatitis
HIV
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Geographical segmentation
Global viral hepatitis and retrovirus diagnostic tests market by geographical segmentation
Viral hepatitis and retrovirus diagnostic tests market in the Americas
Viral hepatitis and retrovirus diagnostic tests market in EMEA
Viral hepatitis and retrovirus diagnostic tests market in APAC
PART 08: Key focus countries
Brazil
China
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
Competitive Scenario
Market Share Analysis 2014
Other prominent vendors
PART 15: Key vendor analysis
Abbott Diagnostics
Alere
Chembio
DiaSorin
Roche Diagnostics
PART 16: Appendix
List of abbreviation